Endocrine Society GUIDELINES Bundle (free trial)

Treatment of Gender-Dysphoric/Gender-Incongruent Persons

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/927900

Contents of this Issue


Page 19 of 19

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2017 All rights reserved ESGEN17123a Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Hembree WC et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. November 2017. 102(11):1–35. Abbreviations DSM, Diagnostic and Statistical Manual of Mental Disorders; DXA, dual-energ y X-ray absorptiometry; E2, estradiol; FSH, follicle stimulating hormone; GD, gender dysphoria; GD/GI, gender dysphoria/gender incongruence; GI, gender incongruence; GnRH, gonadotropin-releasing hormone; MHP, mental health professional; ICD, International Statistical Classification of Diseases and Related Health Problems; IM, intramuscularly; LH, luteinizing hormone; SC, subcutaneously; SQ, sequentially; T, testosterone; UGPS, Ungraded Good Practice Statement Grading System Strength of Recommendation 1 = strong 2 = weak UGPS = ungraded good practice statement Quality of Evidence ⊕⊕⊕⊕ = high ⊕⊕⊕ = moderate ⊕⊕ = low ⊕ = very low

Articles in this issue

Links on this page

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Treatment of Gender-Dysphoric/Gender-Incongruent Persons